Review of Vitalhub Corp.

SEP 11, 2025 - VHI’s track record of compounding capital at a high rate as an acquisitive company is still early but quite solid. We think that if the company manages to execute its acquisitive growth playbook consistently. VHI can continue to grow revenue and earnings in the double-digit range for many years. We think the company is currently trading at a fair valuation; we would be comfortable holding it for the long term. However, as prospective shareholders, we would not be too aggressive in adding to the position at the current price; we are upgrading our rating to B+.